Onderneming Australian Clinical Labs Limited
Aandelen
ACL
AU0000148496
Gezondheidszorgvoorzieningen & -diensten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,42 AUD | -0,41% | -0,82% | -16,26% |
05/03 | Australische aandelen inch lager door mijnbouwers; BBP-gegevens in focus | RE |
28/02 | Transcript : Australian Clinical Labs Limited, H1 2024 Earnings Call, Feb 28, 2024 |
Vakgebied
Aantal werknemers: 5 115
Verkoop per activiteit
AUD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pathology
97,2
%
| 977 | 98,1 % | 678 | 97,2 % | -30,60% |
Clinic
2,1
%
| 13 | 1,3 % | 14 | 2,1 % | +12,86% |
Other
0,6
%
| 6 | 0,6 % | 4 | 0,6 % | -27,59% |
Rental
0,1
%
| 1 | 0,1 % | 1 | 0,1 % | +34,88% |
Verkoop per regio
AUD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Australia
100,0
%
| 996 | 100,0 % | 697 | 100,0 % | -29,99% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Melinda McGrath
CEO | Chief Executive Officer | - | 01-01-15 |
James Davison
DFI | Director of Finance/CFO | - | 01-01-15 |
Tony Landgren
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-09 |
Sean Jackson
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-15 |
Anthony Friedli
COO | Chief Operating Officer | - | 01-01-16 |
Joe Geran
SAM | Sales & Marketing | - | 01-01-15 |
Eric Swayn
PRN | Corporate Officer/Principal | - | 01-01-15 |
Shae Seymour
PRN | Corporate Officer/Principal | - | 01-01-18 |
Chris Brownlow
PRN | Corporate Officer/Principal | - | 01-01-11 |
Eleanor Padman
SEC | Corporate Secretary | - | 28-04-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Alscher
CHM | Chairman | 56 | 01-01-15 |
Leanne Rowe
BRD | Director/Board Member | 67 | 28-04-21 |
Director/Board Member | - | 23-08-23 | |
Andrew Dutton
BRD | Director/Board Member | - | 28-04-21 |
Director/Board Member | - | 01-04-18 | |
Mark Haberlin
BRD | Director/Board Member | 61 | 28-04-21 |
Melinda McGrath
CEO | Chief Executive Officer | - | 01-01-15 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 201 834 015 | 112 579 972 ( 55,78 %) | 1 330 743 ( 0,6593 %) | 55,78 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
HEALIUS LIMITED 4.99% | 36 230 451 | 4.99% | 31 318 689 $ |
2 318 243 | 1.15% | 4 068 424 $ |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-16,26% | 316 mln. | |
-28,69% | 85,35 mld. | |
+14,32% | 81,95 mld. | |
+9,37% | 28,99 mld. | |
-11,43% | 16,98 mld. | |
-0,36% | 16,85 mld. | |
-0,24% | 15,35 mld. | |
+4,32% | 12,42 mld. | |
+33,40% | 12,19 mld. | |
-31,40% | 11,89 mld. |